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Abstract
Background: Apoptosis of lymphocytes is considered a late sequelum in the sepsis cascade. The role of apoptosis
of lymphocytes as a driver of final outcome was investigated.
Methods: Abdominal sepsis was induced after cecal ligation and puncture (CLP) in 31 rabbits. Blood was sampled
at serial time intervals and peripheral blood mononuclear cells (PBMCs) were isolated. Apoptosis of lymphocytes
and monocytes was measured through flow cytometric analysis. PBMCs were stimulated with LPS and Pam3Cys for
the release of tumor necrosis factor-alpha (TNFa). Tissue bacterial growth was quantitatively measured. In a second
set of experiments, CLP was performed in another 40 rabbits; 20 received single intravenous infusions of
ciprofloxacin and of metronidazole 4 hours after surgery.
Results: Animals were divided into two groups based on the percentage of lymphocyte apoptosis at 4 hours after
surgery; less than or equal to 32% and more than 32%. Survival of the former was shorter than the latter (p: 0.017).
Tissue growth was similar between groups. Apoptosis of lymphocytes and of monocytes was lower in the former
group over follow-up. Release of ΤNFa did not differ. The above findings on survival were repeated in the second
set of experiments. Administration of antimicrobials prolonged survival of the former group (p: 0.039) but not of
the latter group (pNS).
Conclusions: Lymphocyte apoptosis at an early time point of experimental peritonitis is a major driver for death. A
lower percentage of apoptosis leads earlier to death. Antimicrobials were beneficial even at that disease state.
Keywords: apoptosis, abdominal sepsis, survival, lymphocytes, antimicrobials
Background
Severe sepsis and septic shock are among the leading
causes of death. It is estimated that almost 3 millions of
cases appear annually in Northern America and in Europe;
35-50% of them die [1]. The abdomen is the second most
common cause of sepsis in the European Intensive Care
Units accounting for 26% of cases [2].
A general scheme of pathogenesis is well acceptable for
all causes of sepsis. According to that scheme, sepsis is
initiated when well-conserved microbial structures known
as pathogen-associated molecular patterns (PAMPs) bind
to receptors embedded either on the cell membranes or
inside the cell cytoplasm of cells of the innate immune sys-
tem, namely blood monocytes and tissue macrophages.
These receptors are known as pattern recognition recep-
tors (PRRs). Toll-like receptors (TLRs) are the best studied
PRRs. Monomers of the peptidoglycan of the cell wall of
Gram-positive cocci bind to TLR2 and lipopolysaccharides
(LPS) of the outer membrane of Gram-negative bacteria
bind to TLR4. The interaction of TLRs with PAMPs ends
with the production of pro-inflammatory cytokines, like
tumor necrosis factor-alpha (TNFa), interleukin (IL)-1b,
IL-6 and IL-8. These pro-inflammatory mediators orches-
trate septic reaction of the host. Soon after this first phase
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ond phase ensues during which monocytes stimulated by
PAMPs are no longer able to secrete a similar large
amount of pro-inflammatory cytokines. Instead during
this second phase a large amount of anti-inflammatory
mediators like IL-10 are produced. This phase is consid-
ered a state of immunosuppression or immunoparalysis
of the host when multiple organ dysfunctions take place
[3]. Apoptosis of lymphocytes predominates during this
stage and it is one of the main drivers leading to immuno-
paralysis [4].
However recent data of our group render questionable
whether the above simplistic scheme may be generalized
for severe sepsis/shock supervening in the field of all
causes of sepsis. More precisely, flow cytometric analysis
of monocytes and of lymphocytes was done within the
first 24 hours upon diagnosis in 505 patients; 100 suffered
from intra-abdominal infections [5]. Results revealed that
advent of severe sepsis/shock in the event of abdominal
sepsis differed considerably compared with sepsis originat-
ing from other sites. This was related with lower expres-
sion of HLA-DR on CD14-monocytes which is an index of
immunoparalysis; greater counts of CD8-lymphocytes; and
greater apoptosis of CD8-lymphocytes compared with
other types of infections.
Based on the latter results it may also be hypothesized
that all causes of abdominal sepsis are not similar in their
ability to stimulate the host’s immune response. Extensive
work over the last two decades was done trying to simu-
late human abdominal sepsis with various animal models.
The most widely applied models are that of intraperitoneal
challenge with LPS or live bugs and that of cecal ligation
and puncture (CLP) [6,7]. The present study aimed to
investigate the importance of the apoptosis of lymphocytes
early in the course of experimental peritonitis for the final
outcome. The study used a model of intra-abdominal
infection after CLP which mimics acute polymicrobial
infections occurring in humans.
Μethods
Ethics Statement
The study received license permit K/8980/11-12-2006
form the Ethics Committee for Animal Experiments of
the Perfecture of Athens. Permit was given in confor-
mance with the following regulations: a) the Greek Presi-
dential approval 30/1996; b) the ministerial decision 167/
1997; c) the laws 1197/1981 and 2015/1992 about the
rights and about protection of laboratory animals; and d)
the directive 160/1991 of the European Union about per-
formance of experiments in laboratory animals.
Animals
A total of 75 white New Zealand male rabbits of a mean
(± SD) weight of 3.19 ± 0.30 kg were studied. All animals
were purchased from the same provider. They were
transported in the animal house 10 days before operation
for acclimatization. They were housed in single metal
cages and had access to tap water and standard balanced
rabbit chow ad libitum. Room temperature ranged
between 18 and 22°C, relative humidity between 55 and
65% and the light/dark cycle was 6 am/6 pm.
Model of peritonitis
The experiments were performed in two sets. In the first
set, 35 animals were studied. The study endpoint of the
initial set of experiments was the relationship between
apoptosis of lymphocytes at 4 and 24 hours with 7-day
survival. Animals were initially sedated by the intramus-
cular injection of 25 mg/kg of ketamine and 5 mg/kg of
xylazine. Anesthesia was maintained by the intramuscu-
lar administration of 15 mg/kg of xylazine at 30-minute
time intervals. In 31 rabbits, after an upper midline
abdominal incision, the peritoneal cavity was entered
and the intestines were displaced to the left. The cecum
was recognized and ligated with a 3.0 suture. Three
holes were performed in the wall of the cecum just
above the suture with a 3.0 needle followed by light
massage of the cecum. The peritoneal cavity and the
abdominal wall were then closed in layers. Animal
resuscitation was done by the continuous intravenous
infusion of normal saline at a rate of 30 ml/hour
through a catheter connected with the vein of the right
ear. Four animals were sham-operated i.e. they were
subject only to abdominal incision and closure. All
experiments were performed on separate days by the
same surgeons.
A volume of 5 ml of blood was sampled from the vein
of the left ear of each animal under aseptic conditions
before the operation, and at 4, 24 and 48 hours. Three ml
were collected into heparin-coated tubes for flow cyto-
metry and stimulation assays. One ml was collected into
pyrogen-free tubes and centrifuged. Serum was kept
refrigerated at -70°C for the measurement of tumor
necrosis factor-alpha (TNFa). Another ml was added
into tubes containing 4 ml of blood culture medium
(Becton Dickinson, Cockeysville Md) and incubated at
35°C for seven days.
After the end of the operation, animals were trans-
ported to their cages. Survival was recorded every 12
hours for a total period of follow-up of 7 days. Every
effort was done to minimize animal suffering. This was
done by the administration of paracetamol suppositories
twice daily starting two hours after the end of the opera-
tion. Within one hour after death autopsy was per-
formed; under sterile conditions, segments from the right
kidney, liver, spleen and lower lobe of the right lung were
taken and placed into separate sterile plastic containers
for quantitative cultures and biopsy. Animals remaining
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initial sedation followed by the rapid intravenous infusion
of phenobarbital. Tissue cultures were drawn from these
animals as described above.
In the second set of experiments, 40 rabbits were stu-
died. In all animals, peritonitis was induced as described
above; blood was sampled at 4 hours after induction of
peritonitis. In 20 animals, single shots of ciprofloxacin and
metronidazole were administered intravenously by one
right ear vein at 4 hours after induction of peritonitis. The
dose of ciprofloxacin was 30 mg/kg (Bayer, Germany) and
that of metronidazole 25 mg/kg (Sanofi Aventis, France),
as reported elsewhere [8,9]. Survival was recorded for
7 days.
The study endpoint was the relationship between apop-
tosis of lymphocytes at 4 and 24 hours with 7-day survival.
To this end, Ethics Committees licensed the study since it
was unavoidable to investigate the impact of apoptosis on
survival without 7-day survival as an endpoint.
Cell apoptosis and cell stimulation
PBMCs were isolated after gradient centrifugation of
heparinized whole blood over Ficoll (Biochrom, Berlin,
Germany). After three consecutive washings in ice-cold
phosphate buffered saline pH 7.2 (Biochrom), PBMCs
were counted in a Neubauer chamber after trypan blue
exclusion of dead cells. Half of PBMCs were stained
with the protein ANNEXIN-V at the flurochrome fluor-
escein isothiocyanate (FITC, emission 525 nm, Immuno-
tech, Marseille, France) and with propidium iodine (PI)
(emission 575 nm, Immunotech). Cells were analyzed
after running through the EPICS XL/MSL flow cyt-
ometer (Beckman Coulter Co, Miami, Florida) with
separate gating for lymphocytes and for monocytes
based on their characteristic FS/SS scattering. Cells
staining positive for ANNEXIN-V and staining negative
for PI were considered apoptotic. Indicative gating on
lymphocytes and on monocytes and staining for
ANNEXIN-V and PI are shown in Figure 1.
The remaining half of PBMCs were distributed into
wells of 96-well plate of a final volume of 0.2 ml per
well with RMPI 1640 enriched with 10% Fetal Bovine
Serum (Biochrom), 2 mM glutamine and 10 mM pyru-
vate at a density of 2 × 10
6 P B M C s / m l .T h e yw e r es t i -
mulated without/with 10 ng/ml of LPS of Escherichia
coli O155:H5 which is a TLR4 ligand (Sigma Co, St.
Louis, USA) or without/with 5 μg/ml of Pam3Cys-SKKK
(EMC Microcollections, Tübingen, Germany) which a
TLR2 ligand. The plates were incubated for 24 hours at
37°C in 5% CO2. After incubation, plates were centri-
fuged and the supernatants were collected and stored at
-70°C until assayed for TNFa. All stimulation assays
were performed in duplicate.
Bioassay for measurement of TNFa
TNFa was measured by a bioassay on L929 fibrosarcoma
cell line, as already described [10,11]. Briefly, confluent
cells were thoroughly washed with Hank’ ss o l u t i o na n d
harvested with 0.25% thrypsin/0.02% EDTA (Biochrom).
Cells were centrifuged, re-suspended in RMPI 1640 sup-
plemented with 10% Fetal Bovine Serum and 2 mM of
glutamine and distributed into a 96-well cell culture plate
at a density of 1 × 10
5 cells/well. The final volume of
fluid into each well was 0.05 ml. After incubation for
2 hours at 37°C at 5% CO2,0 . 0 6m lo fs u p e r n a t a n t so ro f
serum or of standard dilutions of known concentrations
of human TNFa (Sigma, range 5.75-375.00 pg/ml) were
added into each well followed by 0.05 ml of a 0.3 mg/ml
dilution of cycloheximide (Sigma) to inhibit de novo pro-
tein biosynthesis. After over-night incubation, the super-
natant of each well was discarded by aspiration and 0.1
ml of a 0.5 mg/ml methylene blue solution in methanol
99% was added. After ten minutes, the dye was removed
and wells were thoroughly washed three times with 0.9%
sodium chloride. Wells were left to dry and remnants of
the dye in each well became soluble by the addition of
0.1 ml of 50% glacial acetic acid (Merck, Darmstadt,
Germany). Optical density in each well was read at 495
nm (Hitachi Spectophotometer, Tokyo, Japan) against
blank wells and control wells without added serum. Con-
centrations of TNFa were estimated by the reduction of
the optical density of control wells by unknown samples
applying a standard curve generated by standard concen-
trations. All determinations were performed in quadru-
plicate. The inter-day variation of the assay was 13.75%.
Tissue cultures
Tissue segments were weighted and homogenized; one 0.1
ml aliquot was diluted 1:10 into sterile sodium chloride
four consecutive times. Another aliquot of 0.1 ml of each
dilution was plated onto MacConkey agar and incubated
at 35°C for a total period of three days. Plates were incu-
bated at 35°C and the number of viable colonies were
counted into each dilution and multiplied by the appropri-
ate dilution factor. Identification of bacteria was per-
formed by the API20E and the API20NE systems
(bioMerieux, Paris, France). The lower detection limit was
30 cfu/g. Bacterial cells were expressed by their log10
value.
Statistical analysis
Results were expressed by their mean (± SE). Compari-
sons between groups were performed by Mann-Whitney
U test. Survival was estimated by Kaplan-Meier analysis;
groups were compared by the log-rank test. Bacterial
growth was assessed separately for animals that died and
separately for animals that were sacrificed after 7 days.
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the results of tissue cultures, correlation according to
Spearman’s rank of order was done between time until
death and tissue bacterial growth. Any value of p below
0.05 was considered significant after adjustment for mul-
tiple comparisons.
Results
Mean ± SE apoptosis of lymphocytes of the four sham-
operated rabbits and of the 31 rabbits with induced perito-
nitis were 2.4 ± 0.9% and 25.3 ± 3.8% respectively at 4
hours (p: 0.007); 1.1 ± 0.6% and 19.5 ± 4.6% at 24 hours
(p: 0.037); and 2.4 ± 0.7% and 21.2 ± 4.3% at 48 hours (p:
0.032). Respective apoptosis of monocytes were 36.9 ±
10.8% and 42.7 ± 4.3% at 4 hours (p-non significant); 13.7
± 2.9% and 41.6 ± 5.4% at 24 hours (p: 0.042); and 27.8 ±
11.8% and 45.9 ± 6.1% at 48 hours (p: 0.039).
ROC analysis was performed within rabbits subject to
the first set of experimental peritonitis for apoptosis of
lymphocytes and of monocytes at 4 hours and at 24
hours as predictors of death. The only analysis yielding
statistical significance was apoptosis of lymphocytes at 4
hours (AUC: 0.731, 95%CI: 0.544-0.918, p: 0.028). Apop-
tosis of lymphocytes lower than or equal to 32% had spe-
cificity 80% to predict death (Figure 2). This specificity
cut-off has been considered of significance for biomar-
kers to define an event in sepsis studies [12].
Animals were divided into two groups according to
that finding: i) those with lymphocyte apoptosis less
t h a no re q u a lt o3 2 % .T h i sw a sf o u n di n1 8a n i m a l s ;
and ii) those with lymphocyte apoptosis greater than
32% (Figure 2). This was found in 13 animals. Thirteen
(72.2%) and four (20.8%) of them died respectively (p:
0.017, Figure 3).
We hypothesized that at least two explanations may
exist behind that phenomenon: a) apoptosis of lympho-
cytes of the first 4 hours may influence bacterial
Figure 1 Indicative forward and slide scattering of isolated mononuclear cells. Separate gating for lymphocytes and monocytes was done
according to their properties. Flow cytometry panels for apoptosis are also shown. The number of animals and the time of sampling are
indicated.
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may determine death by an immune-related mechanism.
Blood cultures were sterile. Bacterial growth was mea-
sured in the liver, spleen, lung and kidneys of animals
after death or sacrifice. No significant correlation was
found between time to death and tissue bacterial growth
in any tested organ. Bacterial species isolated from tis-
sues of animals were Escherichia coli, Enterobacter cloa-
cae and enterococci. No differences of tissue bacterial
growth were found between animals with apoptosis of
lymphocytes at 4 hours lower than or equal to 32% and
animals with apoptosis of lymphocytes at 4 hours
greater than 32% in the liver, in the spleen and in the
kidney. However, bacterial growth in the lung was
greater within animals with apoptosis of lymphocytes at
4 hours greater than 32% (Figure 4).
The impact of lymphocyte apoptosis on the immune
response of the host involved a study on a) monocytes
apoptosis; and b) the innate immune response. Apopto-
sis of lymphocytes and of monocytes over follow-up is
shown in Figure 5. At that analysis animals are divided
into two groups; those with lymphocyte apoptosis ≤32%
at 4 hours and those with lymphocyte apoptosis > 32%
at 4 hours. At baseline i.e. before induction of peritoni-
tis, the two animal groups did not differ. However, dur-
ing the entire follow-up after induction of peritonitis,
apoptosis of lymphocytes and apoptosis of monocytes
were significantly greater in the group of animals with
lymphocyte apoptosis > 32% at 4 hours (Figure 5).
TNFa produced by PBMCs of these two groups after
stimulation with LPS and Pam3Cys generally did not
differ with the exception of 48 hours. At that time
point, TNFa stimulated by Pam3Cys was greater within
the group of animals with lymphocyte apoptosis ≤32%
at 4 hours. Serum TNFa differed at 4 hours after induc-
tion of peritonitis; it was greater among the group of
animals with lymphocyte apoptosis ≤32% at 4 hours
(Figure 6).
One question needing clarification was the cause of
animal death. Although post-mortem histology was not
done, tissue bacterial growth of intraperitoneal organs i.
e. liver and spleen was much greater among non-surviv-
ing animals at 7 days than among surviving at 7 days.
More precisely, mean ± SE log10 of bacteria in the liver
of non-surviving animals at 7 days were 3.81 ± 0.75 cfu/
g; among surviving animals at 7 days they were 1.98 ±
0.67 cfu/g (p: 0.045). Respective counts of bacteria in
the spleen were 4.48 ± 0.96 cfu/g and 1.86 ± 0.61 (p:
0.031). However, tissue bacterial growth of extraperito-
neal organs i.e. lung and kidney did not differ between
Figure 2 Receiver operator curve (ROC) analysis of apoptosis of lymphocytes at 4 hours to predict survival among rabbits subject to
experimental peritonitis (left panel). According to results of ROC analysis rabbits were divided into two groups; those with apoptosis ≤32%
and those with apoptosis > 32%. The scatterplot of lympchocyte apoptosis is shown in the right panel.
Figure 3 Comparative survival of rabbits subject to
experimental peritonitis. Animals are divided into two groups
based on the percentage of apoptosis of lymphocytes 4 hours after
induction of peritonitis: ≤32% or > 32%.
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Page 5 of 10Figure 4 Tissue bacterial growth in liver, spleen, right kidney and lower right lung lobe of rabbits subject to experimental peritonitis.
Animals are divided into two groups based on the percentage of apoptosis of lymphocytes 4 hours after induction of peritonitis: ≤32% or >
32%. NS: non-significant.
Figure 5 Comparative apoptosis of lymphocytes and of monocytes over consecutive follow-up of rabbits subject to experimental
peritonitis. P values refer to comparisons between animals with percentages of apoptosis of lymphocytes 4 hours after induction of peritonitis
either ≤32% or > 32%; NS: non-significant.
Atmatzidis et al. BMC Infectious Diseases 2011, 11:321
http://www.biomedcentral.com/1471-2334/11/321
Page 6 of 10non-surviving and surviving animals at 7 days. More
precisely, mean ± SE log10 of bacteria in the lung of
non-surviving animals at 7 days were 2.78 ± 0.71 cfu/g;
among surviving animals at 7 days they were 1.96 ±
0.56 cfu/g (p non-significant). Respective counts of bac-
teria in the kidney were 3.92 ± 0.88 cfu/g and 2.16 ±
0.63 (p non-significant). These findings allowed identify
abdominal sepsis as the cause of animal death.
From the 20 untreated rabbits studied in the second set
of experiments, apoptosis of lymphocytes at 4 hours was
≤32% in 14 rabbits and > 32% in six rabbits; 11 (78.6%)
and two of them died (33.3%) respectively. This finding
replicated results of the first set of experiments. From the
20 animals administered single shots of ciprofloxacin and
metonidazole at 4 hours after induction of peritonitis, 11
animals had lymphocyte apoptosis at 4 hours before anti-
biotic infusion ≤32% and nine animals had lymphocyte
apoptosis at 4 hours before antibiotic infusion > 32%. Four
(27.4%) and three (23.3%) of them died respectively. Com-
parison of survival with the respective non-antibiotic
treated animals is shown in Figure 7. It was evident that
infusion of antibiotic prolonged survival of animals with
lymphocyte apoptosis at 4 hours ≤32% but not of animals
with lymphocyte apoptosis at 4 hours > 32%.
Discussion
Sepsis is a syndrome characterized by great heterogene-
ity. Although all patients are ubiquitously characterized
as septic, they greatly differ regarding gender, age, co-
morbid conditions, underlying infections, and offending
pathogens. On that sense, it may be hypothesized that
intra-abdominal infections differ from other types of
infections in the way they trigger sepsis cascade [13].
Some of them develop in the event of another intrab-
dominal sterile critical illness like acute pancreatitis.
Some develop due to slow seeding of bacterial gut con-
tent in the circulation like an abscess or acute diverticuli-
tis. Others develop due to the acute and abrupt leakage
of large amounts of the bowel content like in acute peri-
tonitis after gut rupture [6,14,15]. Although all these
Figure 6 Comparative concentrations of tumor necrosis factor-alpha (TNFa) in serum and in supernatants of peripheral blood
mononuclear cells isolated over consecutive follow-up of rabbits subject to experimental peritonitis after stimulation with LPS or
Pam3Cys. P values refer to comparisons between animals with percentage of apoptosis of lymphocytes 4 hours after induction of peritonitis
either ≤32% or > 32%; NS: non-significant.
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type of stimulation of the immune system of the host.
A model of CLP is used in the present study attempting
to evaluate the effect of bact e r i al o a dr e l e a s e df r o mt h e
gut in the event of intra-abdominal sepsis on the innate
and adaptive immune responses of the host. The study of
rabbits instead of rodents allows better reproducibility of
the experimental conditions. Reproducibility is one major
factor creating diversity in such type of experiments [7].
Rabbits are larger animals than mice. This limits a) diver-
sities created by the surgical team within separate days of
experiments; and b) the impact of sequential blood sam-
pling on survival. Although recent evidence suggest that
daily sampling of volumes as high as 35 μl in mice subject
to CLP do not affect mortality [16], the usage of rabbits
remains indispensable for the present study where daily
sampling of volumes as high as 5 ml is necessary to col-
lect the necessary amount of PBMCs.
Apoptosis of lymphocytes is conceived as sequelea of
severe sepsis [17,18]. In accordance with that an antibody
against receptor PD-1 (programmed-death-1), which is a
negative co-stimulatory molecule on T-lymphocytes, was
administered in mice late after induction of CLP and sep-
sis. Treatment prevented apoptosis of T-lymphocytes and
prolonged survival [19]. However, recent evidence shows
that apoptosis of T-lymphocytes may take place early over
t h ec o u r s eo fs e p s i s[ 2 0 ]a n dan e wi m p o r t a n tr o l eh a s
been suggested for apoptosis of T lymphocytes to regulate
the innate immune response [21].
Our findings corroborate with previous results showing
that apoptosis of lymphocytes is taking place in sepsis
since apoptosis of lymphocytes was greater in rabbits sub-
ject to CLP and sepsis than sham-operated rabbits at all
times of sampling. However, the presented results indicate
that the rate of lymphocyte apoptosis as early as 4 hours
after induction of peritonitis may define final outcome.
The importance of this novel concept is underscored by
the efficacy of treatment outcome. More precisely, admin-
istration of antimicrobials improved survival of animals
that preserved their lymphocytes at 4 hours after induction
of peritonitis. The efficacy of antimicrobials was limited in
those animals with a great level of apoptosis. These find-
ings may suggest that factors other than proper care
impact on outcome from sepsis. However, it is obvious
that the current findings support like never before the
need for a very early start of antimicrobials and for early
debridement of an intra-abdominal infection, as already
suggested in the current treatment guidelines [22].
The mechanism of regulation of final outcome by apop-
tosis of lymphocytes taking place early over the time
course of sepsis is difficult to interpret. According to the
present findings, apoptosis of monocytes is also affected
and this may influence phagocytosis. Other authors sug-
gest that the rate of apoptosis of T lymphocytes in sepsis
may have a direct impact on the process of phagocytosis
[21].
Two main limitations of the present study should be
addressed: a) the lack of commercially-available specific
antibodies allowing discrimination of blood lymphocytes
from blood monocytes in the rabbit. However, their phy-
sical properties of forward scattering and side scattering
allow safe discrimination of these two populations; and
Figure 7 Effect of administration of single doses of ciprofloxacin and of metronidazole 4 hours after induction of experimental
peritonitis in survival. Animals are divided into two groups based on the percentage of apoptosis of lymphocytes 4 hours after induction of
peritonitis: ≤32% or > 32%.
Atmatzidis et al. BMC Infectious Diseases 2011, 11:321
http://www.biomedcentral.com/1471-2334/11/321
Page 8 of 10b) the lack of measurement of the precise lymphocyte
count at every time of sampling. Although this may be of
importance, it could hardly affect the presented results
that are focusing on the apoptotic process per se.
The precise trigger of lymphocyte apoptosis early over
the course of sepsis is unknown. In a recent publication
of our group, one probable explanation is described.
More precisely, serum was isolated from 48 patients with
severe sepsis/shock with the first 12 hours from advent
of organ failures. When CD4-lymphocytes isolated from
healthy volunteers were incubated with patients’ serum,
apoptosis was induced after activation of both the extrin-
sic and the intrinsic apoptotic pathways. This was not the
case whenever CD4-lymphocytes were incubated with
healthy serum. These findings may be interpreted in two
ways: either an inhibitor of apoptosis circulates normally
which is down-regulated early in severe sepsis; or a circu-
latory factor stimulating apoptosis appears early in severe
sepsis [23].
Conclusions
The presented results revealed that lymphocyte apoptosis
at an early time point of experimental peritonitis was a
major driver for death. A lower percentage of lymphocyte
apoptosis within the first 4 hours from the induction of
the septic process led earlier to death. Antimicrobials
could be beneficial even at that state underscoring the
significance of early administration of antimicrobial ther-
apy for the septic patient with intra-abdominal infection.
These findings create the need for similar studies in
other models of sepsis.
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